The Global Innovation Index (GII) is a source of insight into the multidimensional facets of innovation-driven growth. Providing 80 detailed metrics for 129 economies in 2019, the GII has become one of the leading references for measuring an economy’s innovation performance.
Each year the GII presents a thematic component that tracks global innovation. In this year’s edition, it analyzes the medical innovation landscape of the next decade, looking at how technological and non-technological medical innovation will transform the delivery of healthcare worldwide. It also explores the role and dynamics of medical innovation as it shapes the future of healthcare, and the potential influence this may have on economic growth.
- Amid economic slowdown, innovation is blossoming around the world; but new obstacles pose risks to global innovation
- Shifts in the global innovation landscape are materializing; some middle-income economies are on the rise
- Innovation inputs and outputs are still concentrated in very few economies; a global innovation divide persists
- Some economies get more return on their innovation investments than others
- Shifting focus from innovation quantity to innovation quality remains a priority
- Most top science and technology clusters are in the U.S., China, and Germany; Brazil, India, Iran, the Russian Federation, and Turkey also make the top 100 list
- Creating healthy lives through medical innovation requires more investment in innovation and increased diffusion efforts